SmallCapReview.com has been a leading site for information on small cap stocks, penny stocks and microcaps since 1999.
Santarus (Nasdaq: SNTS) $3.21. Today announced that new data from open-label studies evaluating the efficacy and safety of the investigational drug RHUCIN (recombinant human C1 inhibitor) for the treatment of acute attacks of angioedema in patients with Hereditary Angioedema (HAE) were presented at the 7th C1 Inhibitor Deficiency Workshop on May 20 - 22, 2011 in Budapest, Hungary.
New data from 194 treatments with RHUCIN in 57 patients with acute HAE attacks were presented at a satellite symposium at the Workshop. The data were from an open-label extension study from one of two randomized controlled studies that formed the basis for regulatory approval in Europe. The median time to beginning of relief of symptoms across treatments for repeat attacks was approximately 60 minutes with an overall response rate of 87% and no relapses. No product-related adverse reactions were observed during this study. This data from the European open-label study is consistent with previously announced results from an open-label extension study conducted in North America. The safety dataset of RHUCIN now includes a total of 714 administrations in 190 subjects.
What They Do: Santarus, Inc. is a specialty biopharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by physician specialists.
Identive Group (Nasdaq: INVE) $3.04. Today announced the signing of a Value Added Reseller (VAR) agreement with NXP Semiconductors, under which the companies will work together to identify and address emerging opportunities in the secure identification market by promoting and selling Identive's identification products, based on NXP's RFID semiconductor technology. The agreement is for an initial three-year term and is then renewable on an annual basis.
Under the VAR agreement, NXP and Identive will work closely to identify, jointly assess and mutually address new market opportunities for secure identification applications and technologies. The agreement builds on the existing business relationship between the two companies, which currently includes cooperation on secure identification applications such as contactless readers for government and employee ID programs, near field communications (NFC) stickers for mobile phones and smart posters, and radio frequency identification (RFID) tags for tracking assets such as pharmaceutical products or library books. The expanded cooperation will increase the span and reach of both companies, commercially and technologically, and allow the 2 companies to address new markets with complete solution offerings such as NFC in mobile consumer products, with dedicated resources at both companies.
What They Do: Identive Group is an international technology company focused on building the world's signature group in secure identification-based technologies.
About SmallCapReview
Copyright SmallCapReview. SmallCapReview.com is a leading site for news on small-caps, penny stocks and microcaps. SmallCapReview has built a loyal opt-in following for their investor products by providing a newsletter at no cost, sent to subscribers, highlighting select stocks in play, to register visit www.SmallCapReview.com.
